Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination
Patent No. EP3294325 (titled "Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination") was filed by Biontech Cell&Gene Therapies on May 9, 2016. The application was issued on Jul 26, 2023.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3294325
- Application Number
- EP16724861A
- Filing Date
- May 9, 2016
- Status
- Granted And Under Opposition
- Jun 23, 2023
- Publication Date
- Jul 26, 2023
- External Links
- Slate, Register , Google Patents